MAB21L2 gene

Overview

Gene (OMIM No.)
Function of gene/protein
  • Protein: MAB21-like 2
  • Required for normal eye development and thought to be involved in neural development
  • Believed to be a downstream target of TBFB growth factor signalling pathway
Clinical phenotype
(OMIM phenotype no.)
  • Microphthalmia/coloboma and skeletal dysplasia syndrome (#615877)
  • Also known as microphthalmia, syndromic 14
Inheritance
  • Autosomal dominant
  • Autosomal recessive in one family
Ocular features
Systemic features
  • Skeletal dysplasia (contractures of large joints, hypoplastic femoral condyles, rhizomelia)
  • Intellectual disability
Key investigations
  • B-scan USS to measure axial length to document microphthalmia
  • Electrophysiology
  • MRI brain and orbit
  • Systemic assessment with a paediatrician and other relevant specialists
Molecular diagnosisNext generation sequencing
  • Targeted gene panels (MAC)
  • Whole genome sequencing
ManagementOcularSystemic
  • Multidisciplinary approach
Therapies under research
  • None at present
Further information

Jump to top


References

  1.  Deml B, Kariminejad A, Borujerdi RH, Muheisen S, Reis LM, Semina EV. Mutations in MAB21L2 result in ocular Coloboma, microcornea and cataracts. PLoS Genet. 2015;11(2):e1005002
  2.  Horn D, Prescott T, Houge G, et al. A Novel Oculo-Skeletal syndrome with intellectual disability caused by a particular MAB21L2 mutation. Eur J Med Genet. 2015;58(8):387‐391
  3.  Rainger J, Pehlivan D, Johansson S, et al. Monoallelic and biallelic mutations in MAB21L2 cause a spectrum of major eye malformations. Am J Hum Genet. 2014;94(6):915‐923

Jump to top

Updated on November 30, 2020
Was this article helpful?